A new test for tuberculosis (TB) could dramatically improve the speed and accuracy of diagnosis for one of the world’s deadliest diseases, enabling health care providers to report results to patients within minutes, according to a study published this week in the journal Angewandte Chemie.
Jeffrey Cirillo, Ph.D., professor at the Texas A&M Health Science Center College of Medicine, in collaboration with GBDbio, a Texas A&M spinoff company, and investigators at Stanford University, have identified a new chemical compound to spot the bacteria that cause TB with a level of sensitivity that currently takes months to produce; and results of the first human clinical trial data are promising. Findings show the test can determine that a patient has tuberculosis with 86 percent sensitivity and 73 percent specificity. Smear microscopy, the most widely used test in the world, has a significantly lower ability to detect TB, ranging between 50 to 60 percent sensitivity.
Although preventable, TB claims three lives every minute, making it the second leading cause of mortality from an infectious disease in the world. Spread through the air when an individual with active TB infection coughs or sneezes, reports show that if left untreated, a person with active TB infects an average of 10 to 15 people each year, leaving a great need for faster, more reliable testing.
Cirillo’s latest breakthrough perfects the technology behind the test. Using a fluorescent substrate, the device targets BlaC – an enzyme produced by the bacteria that cause TB – as an indicator of the bacteria’s presence. Until now, it has not been possible to target a specific TB enzyme for diagnosis.
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
- Private sector tuberculosis notifications in Karnataka rise by over 35% in 2019on June 27, 2020 at 11:06 am
Private-sector tuberculosis (TB) notifications in the State have been on the rise for the last few years. As many as 91,703 TB cases [both private and public] were reported in Karnataka in 2019, which ...
- Corona could lead to 95,000 tuberculosis deaths in Indiaon June 26, 2020 at 5:00 pm
A recent study published in the European Respiratory Journal (ERJ) estimates that the COVID-19 pandemic could result in 95,000 people dying of tuberculosis in India. This has been estimated majorly ...
- St Vincent’s Hospital: Sydneysiders at risk after tuberculosis outbreakon June 26, 2020 at 1:13 pm
Hundreds of patients and staff members at St Vincent’s Hospital have been exposed to a tuberculosis outbreak after a cluster of five people tested positive to the disease.
- Tuberculosis cases linked to NSW hospitalon June 26, 2020 at 10:34 am
A Sydney hospital is working to identify staff, patients and members of the public who may have been exposed to tuberculosis after identifying a small cluster of cases at the facility. Genomic ...
- Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescenceon June 26, 2020 at 8:13 am
The precise nature of the local immune responses in lung tuberculosis (TB) granulomas requires a comprehensive understanding of their environmental complexities. At its most basic level, a granuloma ...
- Indonesia should explore whether tuberculosis vaccine BCG can protect against COVID-19on June 26, 2020 at 2:11 am
Indonesia, one of the 17 countries in the world with existing infrastructure to manufacture BCG vaccine, should perform large-scale clinical trials to test its use for COVID-19.
- Tuberculosis cases and deaths predicted to spike due to COVID-19on June 24, 2020 at 1:09 pm
A new study estimates that at least 110,000 additional deaths from tuberculosis in China, India and South Africa unless health services maintained and strengthened.
- COVID-19 pandemic could increase the global burden of tuberculosison June 24, 2020 at 8:38 am
The global COVID-19 pandemic could significantly increase the global burden of tuberculosis (TB) due to disruptions to health services, and delays to diagnosis and treatment, according to new ...
- Mitigating the impact of COVID-19 on countries affected by HIV, tuberculosis and malariaon June 24, 2020 at 1:31 am
English Analysis on World and 6 other countries about Contributions, Disaster Management, Children, Women, Epidemic and more; published on 24 Jun 2020 by Global Fund ...
- Mesenchymal stem cells offer a drug-tolerant and immune-privileged niche to Mycobacterium tuberculosison June 16, 2020 at 2:12 am
Treatment of tuberculosis needs to be taken for several weeks, despite good potency of drugs in vitro. Here, the authors show that mesenchymal stem cells can harbor Mycobacterium tuberculosis ...
via Bing News